Roger Dreiling is an interventional cardiologist currently practicing with Cardiovascular Specialists of Lawrence in Kansas. He has over 30 years of experience in interventional cardiology. He received his bachelor's degree in pharmacy from the University of Kansas and his medical degree from the University of Kansas School of Medicine. He has held previous positions in Oregon, Missouri, and Kansas.
1. Curriculum Vitae
Roger J. Dreiling, M.D., FACC
rogerdreiling@aol.com
Cell: 785-766-2787
Date of Birth: September 16, 1951
Place of Birth: Hays, Kansas
Current Cardiovascular Specialists of Lawrence
Business 1130 W 4th Street, Suite 2050
Address Lawrence, KS 66044
Present
Position Interventional Cardiologist, Consulting Cardiologist Oct 2009-Present
Cardiovascular Specialists of Lawrence
Served as Medical Director Oct 2009 – Oct 2014
Lawrence, Kansas
Phone: 785-841-3636 Fax: 785-841-1604
Previous Interventional Cardiologist, Consulting Cardiologist
Positions Cardiovascular Consultants Sept 2008 – Nov 20009
Lawrence, Kansas and Kansas City, Missouri
Medical Director Jan 1998 – Aug 2008
Interventional Cardiologist, Consulting Cardiologist
Samaritan Cardiology
Corvallis Oregon 97330
541-768-5205 Office
G. D. Searle*
Director Aug 1997-Jan 1998
Clinical Research – Cardiovascular
G. D. Searle
Associate Director June 1996 - July 1997
Clinical Research – Cardiovascular
Cardiology Services P.A. Shawnee Mission, Kansas
(913) -722-0080
Interventional Cardiologist July 1984 - June 1996
Education: Saint Joseph’s Military Academy
Hays, Kansas 67601
High School Graduating Class of 1969
University of Kansas
Bachelor of Science, Pharmacy with Distinction May 1974
University of Kansas
Doctor of Medicine May 1978
House Staff Medical Internship, University of Kansas 1978-1979
Training: Medical Residency, University of Kansas 1979-1981
Medical Chief Resident, University of Kansas 1981-1982
2. 2
Fellow in Cardiology, University of Kansas 1982-1984
Memberships: American Medical Association
American College of Cardiology
Kansas Medical Association
Board
Certification: Diplomat, National Board of Medical Examiners 1979
Board Certified, American Board of Internal Medicine 1982
Board Certified Cardiology (# 84405) 1985
Board Certified Interventional Cardiology (#84405) 1999
Board Recertification Interventional Cardiology (#84405) 2009
Honors and
Awards: National Science Foundation Research Award 1972
University of Kansas
Robert Irsay Award in Medicinal Chemistry 1974
University of Kansas School of Pharmacy
Outstanding Student in Surgery 1978
University of Kansas School of Medicine
Alpha Omega Alpha Honors Medical Society 1978
Best Intern on Medical Service Award 1979
Kansas University Medical Center
Department of Internal Medicine
Milton McGreevy Award in Internal Medicine 1980
Kansas University Medical Center
Department of Internal Medicine
Governor Elect American College of Cardiology 1992
Regional Governor - Kansas 1993-1996
American College of Cardiology
Listed in “Best Doctors in Kansas City ” The Other Side 1(2), 4/15/95
Samaritan Health Services
Northwest Track Medical Students Teacher of the Year 2007-2008
Medical: Kansas Certificate 18135 Active
License Oregon Certificate MD20932 Inactive
California Certificate G87899 Inactive
Missouri Certificate Active Inactive
Arizona Certificate Inactive Inactive
Publications:
Books:
“The Medical Book of Lists: A Primer of Differential Diagnosis in Internal Medicine”, Yearbook Medical
Publishers, 1983
3. 3
Editorials:
Dunn, M.I., and Dreiling R.J., “Streptokinase”, Arch Internal Medicine, 1985, 145(8), 1381.
Articles and Abstracts
Long-Term Treatmentwith a PlateletGlycoprotein-Receptor Antagonistafter Percutaneous CoronaryRevascularization.
The EXCITE Trial Investigators. N Engl J Med 2000;342-1316-24
The EXCITE IVUS SubstudyInvestigators. Restenosis Following SixMonths Administration ofXemilofiban,an Oral
IIb/IIIa Antagonist:An IVUS Substudy of the EXCITE Trial. Circulation 1999;100(18):I-511 (Abstract No. 2691)
Serruys, P.W, O’Neill,W.W., Knudtson,M., Dreiling,R.J., Anders, R.J., Kleiman,J.H., Gerrit-Ann van Es. The EXCITE
Investigators Throaxcenter and Cardilaysis,Rotterdam,The Netherlands;Wm.BeaumontHospital,Royal Oak, MI; G. d.
Searle & Co., Skokie Il, USA Restenosis Following SixMonths Administration ofXemilofiban,an Oral IIb/IIIa Antagonist:
A Sub-Study of the EXCITE Trial. J. A. C. C. 1999;33: 87A
Kereiakes,D.J., Kleiman,N.S., Ferguson,J.J. Masud, Z., Broderick T., Abbottsmith,CW, Runyon JP, Anderson, LC,
Anders, Dreiling,R.J., Hantsbarger GL,Bryzinski, Brian, Topol,EJ. Pharmacodynamic Efficacy, clinical Safety, and
Outcomes After Prolonged PlateletGlycoprotein IIb/IIIa Receptor Blockade With Oral Xemilofiban. Circulation
1998;98:1268-1278
Kereiakes,D.J., Kleiman,N.S., Ferguson,J.J. Anders, R.J., Hantsbarger,G.L., Borton, M.A., and Dreiling,R.J.
Sustained PlateletGlycoprotein IIb/IIIa Blockade with Oral Xemilofiban: Final Results ofthe Orbit Trial. Circulation 1997;
96: I-358
Baldwin,T. F., Lash,R. E., Whitfield, S.S., Toalson,W. B., Murphy, J. W., Dreiling,R. J., Hawkins,J. W., Hansell,H.N.,
“Directional CoronaryAtherectomy in Acute Myocardial Infarction” J. Invasive Cardiology,1993,5, (8), 228-294
Dreiling,R. J., Dunn,M.I., “Managementof the Uncomplicated Myocardial Infarction”, Modern Medicine, May 1986,60 -68
Chrysant, S. G., Gollub,S., Dunn,M. I., Bal, I. S., Dreiling, R.J., Konijeti,J.R., “Hemodynamic and Metabolic Effects of
Enalapril in Patients with Heart Failure”,Clinical Cardiology,1985,8, 585-590
Dunn,M. I., Dreiling,R. J., “When Heart Disease Leads to PulmonaryEdema”,Journal ofRespiratoryDisease,198 4,
5(1), 127-136
Dunn,M. I., Dreiling,R. J., “Cardiovascular Diseases”,J.A.M.A., 1984,252(16),2177-2180
Dreiling,R. J., Dunn,M. I., “Congestive HeartFailure”, Comprehensive Therapy, 1984,10(9), 54-59
Gladden,J. R., Dreiling,R. J., et.al., “Two-Dimensional Echocardiographic Features ofMultiple Right Atrial Myxomas”,
Am. J. Cardiol. 1984
Dunn,M. I., Dreiling,R. J., “Cardiogenic PulmonaryEdema”,Hospital Practice,1983,August,58A-58K
Dunn,M.I., Dreiling,R. J., “Cardiovascular Causes of Syncope”, Journal of Cardiovascular Medicine,1983,8(12),1249-
1257
Lynch, J. M., Dreiling,R. J., Hodges,G. R., et.al., “Generalized Exfoliation Associated with Staphylococcus Aureus
Infection”, Southern Med. Journal,1981, 74(1),24-27
Refshauge.C.,Kissinger,P.T., Dreiling,R., Blank,L, Freeman,R., Adams,R.N. “New High-Performance Liquid-
Chromatographic Analysis ofBrain Catecholamines.” Life Sci, 1974; 14: 311-322
Kissinger,P.T., Refshauge .C,Dreiling,R., Adams,R.N.,” Electrochemical Detector for Liquid Chromatographywith
Picogram Sensitivity. “ Analytical Letters 1973; 6:465-477
R.L. McCreery, R. Dreiling,R.N. Adams,"Voltammetry in Brain tissue,Quantitative Studies ofDrug Interactions", Brain
Res., 1974, 73, 23.
R.L. McCreery, R. Dreiling,R.N. Adams,"Voltammetry in Brain Tissue,the Fate of 6-Hydroxydopamine", Brain Res.,
1974,73, 15.
4. 4
Appointments:
Kansas University Medical Center -- Joint Appointment
Clinical Assistant Professor
Department of History of Medicine
Department of Medicine/Cardiovascular Diseases 1985-1996
Adjunct Professor of Clinical Pharmacy 2005-2008
Oregon State University
Corvallis, Oregon 97330